Summary & Overview
CPT 93261: Subcutaneous Defibrillator System Interrogation and Evaluation
CPT code 93261 represents the professional service of interrogating and evaluating a subcutaneous implantable cardioverter-defibrillator (S-ICD) lead system and preparing a report of findings. This evaluation is a key component of cardiac device management, supporting patient safety by confirming appropriate device function and identifying issues such as sensing problems, lead integrity concerns, or therapy delivery anomalies. Nationally, consistent reporting and billing for device interrogations affect quality tracking and resource allocation across outpatient and clinic settings.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides readers with a concise overview of the code’s clinical context, typical sites of service, and administrative considerations relevant to billing and coding teams. It also outlines what to expect in benchmarking and policy updates when data is available, while noting where input data is not provided.
Readers will learn: the clinical purpose of CPT code 93261, the typical care settings where the service occurs, how major payers cover device interrogation services generally, and which operational elements—such as documentation and reporting—are central to accurate coding. Data not available in the input is explicitly noted where applicable.
Billing Code Overview
CPT code 93261 describes an interrogation and evaluation of a subcutaneous implantable cardioverter-defibrillator (S-ICD) lead system. The service involves the provider interrogating the device to examine its functioning and preparing a report of findings.
-
Service type: Device interrogation and evaluation
-
Typical site of service: Hospital outpatient department, ambulatory surgical center, clinic, or device clinic where implanted cardiac device follow-up is performed.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a history of ischemic cardiomyopathy and recurrent ventricular tachycardia presents to the cardiac device clinic for routine evaluation of an implanted subcutaneous implantable cardioverter-defibrillator (S-ICD). The clinic visit is scheduled as a device interrogation and evaluation to review sensing vectors, battery status, lead integrity, delivered therapies, and stored arrhythmia events. A cardiac electrophysiology nurse or device technician performs the initial programmer interrogation, downloads device data, and reviews device diagnostics. The electrophysiologist reviews the downloaded report, assesses impedance trends, charge time, and therapy appropriateness, documents findings, and prepares a formal written report of the interrogation and clinical interpretation. The service typically occurs in an outpatient cardiac device clinic, ambulatory surgery center, or hospital outpatient department and may be billed when the provider personally interrogates and evaluates the subcutaneous lead defibrillator system and prepares a report using code 93261.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician’s professional interpretation and report for the device interrogation separate from technical services. |